U.S. government agencies have different criteria for sanctioning adversaries and preventing them from engaging in the U.S. economy. Our biggest foreign adversaries, like China, benefit from this lack of interagency coordination, which must come to an immediate...
News
Latest News
House of Representatives Passes Three Rubio Bills to Counter Communist China
Three bills, led by U.S. Senator Marco Rubio (R-FL), which prevent the Chinese Communist Party from taking advantage of our nation, has successfully passed the U.S. House of Representatives and are now awaiting Senate consideration. “The House of Representatives has...
Rubio to Secretary Austin: Communist China Shouldn’t Be Exposed to U.S. Military Drills
Annually, Brazil hosts “Operation Formosa” which are military exercises conducted by several nations. This year, the Chinese Communist Party’s armed wing, the People’s Liberation Army (PLA), has been invited to participate. Beijing participating in the exercises,...
Rubio, McCormick, Colleagues: No Visas for Terrorist Sympathizers
Since Hamas’s horrific October 7, 2023 terrorist attack against Israel, U.S. cities and campuses are seeing a disturbing rise in antisemitic, pro-terrorist violence. There remains concern that participants in these acts are here on visas and are not being held...
Rubio, Colleagues Introduce Resolution Recognizing USS Carney
U.S. Navy destroyer USS Carney, homeported at Naval Station Mayport, Florida after an eight-month deployment to the Middle East. This historic deployment saw 51 engagements with Iranian-backed terrorists, the most engagements with a foreign adversary by a Naval vessel...
Rubio Slams Biden-Harris Admin for Counter-productive “Solutions” to Parental Stress
The Office of the Surgeon General announced a public advisory warning of alarmingly high levels of parental stress. The advisory and the Surgeon General’s accompanying op-ed, offered a set of “solutions” that fail to address the actual wants and needs of struggling...
Rubio, Bennet Applaud House Passage of RACE for Children Act
Washington, D.C. – U.S. Senators Marco Rubio (R-FL) and Michael Bennet (D-CO), along with Senators Cory Gardner (R-CO) and Chris Van Hollen (D-MD), today applauded the passage in the U.S. House of Representatives of the RACE for Children Act as part of the FDA User Fees reauthorization bill.
In February, Senators Rubio, Bennet, Gardner, and Van Hollen introduced the Research to Accelerate Cures and Equity (RACE) for Children Act to support the development of innovative and promising cancer drugs for children.
“Today’s passage of the RACE for Children Act in the House is great news,” said Rubio. “We are one step closer to developing innovative and promising cancer drugs for children across the country who desperately need them. I urge my colleagues to support this bill when it comes before the Senate. It is crucial this legislation becomes law so that children with cancer have hope for a better future.”
“Today’s passage of the RACE for Children Act in the House is a significant step for children around the country who deserve lifesaving treatments,” said Bennet. “We should be able to tell parents with kids who are battling cancer that we’re doing everything we can to develop breakthrough drugs to treat their children. Today’s House vote brings us closer to that goal. We are thankful to Chairman Lamar Alexander for his leadership in supporting this legislation. And we look forward to the User Fees bill coming before the Senate.”
The bipartisan RACE for Children Act, first introduced in the 114th Congress, would update the Pediatric Research Equity Act (PREA) to reflect the latest advances in cancer drugs. Congress enacted PREA in 2003 to address the scarcity of information about how to treat children with drugs developed and approved for adults. Although PREA has resulted in new information on how to treat children for a multitude of drugs over the years, there are still limited pediatric studies for cancer drugs. This bill would update PREA by ensuring that the most innovative molecular-targeted drugs for cancer are also studied for children when appropriate. The bill also directs the Food and Drug Administration (FDA) to work with manufacturers to speed up studies for drugs that treat other serious or life-threatening diseases in children.
Numerous pediatric oncology groups support the RACE for Children Act, including St. Jude Children’s Research Hospital, St. Baldrick’s Foundation, Live Like Bella Childhood Cancer Foundation, Nemours Children’s Health System, Arnold Palmer Hospital, Moffitt Cancer Center, Kids v. Cancer, the Children’s Hospital Colorado, Children’s Hospital of Philadelphia, Children’s Medical Center of Dallas, Dana-Farber Cancer Institute, Duke University Medical Center, Harvard Medical School, MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, NYU Langone Medical Center, Texas Children’s Hospital, the Alliance for Childhood Cancer, the American Society of Clinical Oncology, and the American Cancer Society Cancer Action Network.